Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.30 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10082817 | 0.88 | CYP1A2 (0.36) | TLR4CYP1A2 | |
| SCHEMBL572011 | 0.86 | CYP1A2 (0.42) | CYP1A2 | |
| SCHEMBL8201032 | 0.84 | KMT2A (0.40) | NPC1RAB9A | |
| SCHEMBL3477821 | 0.83 | TLR4 (0.35) | TLR4LMNA | |
| SCHEMBL12835081 | 0.82 | TLR4 (0.33) | TLR4 | |
| SCHEMBL2691050 | 0.79 | — | — | |
| SCHEMBL6907548 | 0.77 | TLR4 (0.34) | TLR4 | |
| SCHEMBL13091313 | 0.76 | MAPT (0.30) | CYP1A2 | |
| Acetic Acid SCHEMBL9521345 | 0.75 | LMNA (0.34) | TLR4LMNA | |
| SCHEMBL6869112 | 0.73 | METAP1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| US-20240239994-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | claimed |
| EP-4319716-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | Firmenich SA (CH) | 2024-02-14 | — | — | EP | claimed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2023-03-23 | — | — | US | claimed |
| WO-2022253712-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | FIRMENICH SA (CH) | 2022-12-08 | — | — | WO | claimed |
| EP-4084769-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | Firmenich SA (CH) | 2022-11-09 | — | — | EP | claimed |
| US-11364184-B2 | Perfume compositions | GIVAUDAN SA (CH) | 2022-06-21 | — | — | US | claimed |
| WO-2021214205-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2021-10-28 | — | — | WO | claimed |
| US-20190276469-A1 | Cyclic Ketals As Fragrance Precursor Compounds | HENKEL AG & CO. KGAA (DE) | 2019-09-12 | — | — | US | claimed |
| EP-3523414-A1 | CYCLIC KETALS AS FRAGRANCE PRECURSOR COMPOUNDS | Henkel AG & Co. KGaA (DE) | 2019-08-14 | — | — | EP | claimed |
| WO-2018095814-A1 | CYCLIC KETALS AS FRAGRANCE PRECURSOR COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2018-05-31 | — | — | WO | claimed |
| WO-2010064239-A1 | APPARATUS AND METHODS FOR DIAGNOSING RENAL DISORDERS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2010-06-10 | — | — | WO | claimed |
| EP-1599181-A1 | IMPROVEMENTS IN OR RELATING TO FLAVOUR COMPOSITIONS | Quest International Services B.V. (NL) | 2005-11-30 | — | — | EP | claimed |
| WO-2004073668-A1 | IMPROVEMENTS IN OR RELATING TO FLAVOUR COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2004-09-02 | — | — | WO | claimed |
| EP-0980863-A1 | Oxime carboxylic acid derivatives | Givaudan Roure (International) S.A. (CH) | 2000-02-23 | — | — | EP | claimed |
| EP-0878497-A2 | Fragrance precursor compounds | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-11-18 | — | — | EP | claimed |
| WO-2026087780-A1 | CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-0887335-A1 | Precursor compounds | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-12-30 | — | — | EP | disclosed |
| EP-0878497-A2 | Fragrance precursor compounds | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | PORCN, FAAH2, FASN | TLR4 2339/4885CYP1A2 153/4885NPC1 2429/4885 |
| US-20190276469-A1 | Cyclic Ketals As Fragrance Precursor Compounds | KCNK5, KLK5, KCNA1 | TLR4 4496/4885CYP1A2 2234/4885NPC1 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.